Rapid estimation of piperine in black pepper: Exploration of Raman spectroscopy

INTRODUCTION

The major chemical marker of black pepper (Piper nigrum L) is piperine and its estimation is extremely important for quality assessment of black pepper. The methods for piperine quantification, to date, are laboratory based and use high end instruments like chromatographs, which require tedious sample processing and cause sample destruction.

OBJECTIVES

In this article, we present a simple, rapid and green analytical method based on Raman spectroscopy for the quantitative assessment of piperine.

MATERIAL AND METHODS

To assess the potential of the technique, we report the complete vibrational characterisation of the piperine with density functional theory (DFT) calculations.

RESULTS

The theoretical peaks were obtained at 1097 cm^-1 , 1388 cm^-1 , 1528 cm^-1 , 1578 cm^-1 , and at 1627 cm^-1 , and this result was verified in a Raman spectrometer followed by a preliminary experiment. Twenty black pepper samples were analysed using high-performance liquid chromatography (HPLC) and used as reference data for Raman analysis. The Raman shift spectra were analysed using partial least squares (PLS) and good prediction accuracy with correlation coefficient of prediction (Rp² ) = 0.93, root mean square error of prediction (RMSEP) = 0.13 and residual prediction deviation (RPD) = 3.9 obtained.

CONCLUSIONS

The results demonstrate the efficacy of the Raman technique for the estimation of piperine in the dry fruit of Piper nigrum.

Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking

Due to the lack of effective pharmacotherapy options to treats Alzheimer's disease, new strategies have been approached in the search for multi-target molecules as therapeutic options. In this work, four indole alkaloids, geissoschizoline, geissoschizone, geissospermine, and 3',4',5',6'-tetradehydrogeissospermine were isolated from Geissospermum vellosii (Pao pereira) and evaluated for their anticholinesterase activities. While geissospermine inhibited only butyrylcholinesterase (BChE), the other alkaloids behaved as non-selective inhibitors of acetylcholinesterase (AChE) and BChE. In cell viability tests, only geissoschizoline was not cytotoxic. Therefore, geissoschizoline actions were also evaluated in human cholinesterases, where it was twice as potent inhibitor of hBChE (IC₅₀ = 10.21 ± 0.01 µM) than hAChE (IC₅₀ = 20.40 ± 0.93 µM). On enzyme kinetic studies, geissoschizoline presented a mixed-type inhibition mechanism for both enzymes. Molecular docking studies pointed interactions of geissoschizoline with active site and peripheral anionic site of hAChE and hBChE, indicating a dual site inhibitor profile. Moreover, geissoschizoline also played a promising anti-inflammatory role, reducing microglial release of NO and TNF-α at a concentration (1 μM) ten and twenty times lower than the IC₅₀ values of hBChE and hAChE inhibition, respectively. These actions give geissoschizoline a strong neuroprotective character. In addition, the ability to inhibit hAChE and hBChE, with approximate inhibitory potencies, accredits this alkaloid for therapeutic use in the moderate to severe phase of AD. Thus, geissoschizoline emerges as a possible multi-target prototype that can be very useful in preventing neurodegeneration and restore neurotransmission.